Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Na.O3S.7H2O |
Molecular Weight | 252.15 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])=O
InChI
InChIKey=WMJRPJZQQSSDBU-UHFFFAOYSA-L
InChI=1S/2Na.H2O3S.7H2O/c;;1-4(2)3;;;;;;;/h;;(H2,1,2,3);7*1H2/q2*+1;;;;;;;;/p-2
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O3S |
Molecular Weight | 82.079 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulfites are compounds that contain the sulfite ion. The sulfite ion is the conjugate base of bisulfite. Although its acid is elusive, its salts are widely used. Sulfite is used in the photography industry to protect developing solutions from oxidation, in the pulp and paper industry, in water treatment as an oxygen scavenger agent, as a desulfurizing and dechlorinating agent in the leather industry and as a bleaching agent in textile industry. Sodium sulfite is a component in many pharmaceuticals, which is effective to maintain the potency and stability of drugs. It is added to a number of drug preparations as an antioxidant and antimicrobial agent. Sulfite is used as a food preservative. Topical, oral or parenteral exposure to sulphites has been reported to induce a range of adverse clinical effects in sensitive individuals, ranging from dermatitis, urticaria, flushing, hypotension, abdominal pain and diarrhoea to life-threatening anaphylactic and asthmatic reactions. Exposure to the sulphites arises mainly from the consumption of foods and drinks that contain these additives; however, exposure may also occur through the use of pharmaceutical products, as well as in occupational settings. Sulfite is accepted for use as a food additive in Europe. Sodium sulfite is generally recognized as safe by FDA. It is included in FDA Inactive Ingredients Database (epidural, IM, IV, and SC injections; inhalation solution; ophthalmic solutions; oral syrups and suspensions; otic solutions; topical creams and emulsions). Included in nonparenteral medicines licensed in the UK.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. | 1977 Apr |
|
[Determination of fibrinogen concentration in blood plasma by the sulfite precipitation method]. | 1979 Jan-Feb |
|
Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces. | 1983 Jan |
|
High-performance liquid chromatographic measurement of exogenous thiosulfate in urine and plasma. | 1984 Aug 1 |
|
Electrochemical detection of human brain transmitter amino acids by high-performance liquid chromatography of stable o-phthalaldehyde-sulphite derivatives. | 1991 |
|
High performance liquid chromatographic determination of bound sulfide and sulfite and thiosulfate at their low levels in human serum by pre-column fluorescence derivatization with monobromobimane. | 1992 Nov |
|
Molybdenum: an essential trace element. | 1993 Dec |
|
Sulfite stimulates NADPH oxidase of human neutrophils to produce active oxygen radicals via protein kinase C and Ca2+/calmodulin pathways. | 1993 Jun |
|
Responses of human neutrophils to sulfite. | 1994 Mar |
|
Effect of sulphite on the oxidative metabolism of human neutrophils: studies with lucigenin- and luminol-dependent chemiluminescence. | 1995 Jan-Feb |
|
Media for Aeromonas spp., Plesiomonas shigelloides and Pseudomonas spp. from food and environment. | 1995 Jun |
|
Metabolism of methanesulfonic acid involves a multicomponent monooxygenase enzyme. | 1996 Feb |
|
Comparison of a new, bismuth-iron-sulfite-cycloserine agar for isolation of Clostridium perfringens with the tryptose-sulfite-cycloserine and blood agars. | 1997 Feb |
|
Nutritional aspects of dissimilatory sulfate reduction in the human large intestine. | 1997 Nov |
|
Sulfite is released by human neutrophils in response to stimulation with lipopolysaccharide. | 1998 Nov |
|
Ahomocysteinemia in molybdenum cofactor deficiency. | 1998 Sep |
|
Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. | 2001 Jun 21 |
|
The effect of a denture adhesive on the colonization of Candida species in vivo. | 2003 Sep |
|
A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. | 2004 Oct 8 |
|
Effect of sulfite on red blood cell deformability ex vivo and in normal and sulfite oxidase-deficient rats in vivo. | 2005 Sep |
Sample Use Guides
The acceptable daily intake for sodium sulfite has been set at up to 350 mg/kg body-weight daily.
Route of Administration:
Oral
Sulfite was rapidly converted to sulfate by isolated rat hepatocytes at concentrations ranging from 200 umol/L to 2 mmol/L. Incubation of isolated rat hepatocytes with 0.5, 1, or 2 mmol/L sulfite resulted in a
time-dependent increase in the amount of free glutathione, but not cysteine, associated with the cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:46:03 GMT 2023
by
admin
on
Fri Dec 15 18:46:03 GMT 2023
|
Record UNII |
4YS288TJUI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID8043949
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | |||
|
100000079559
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | |||
|
4YS288TJUI
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | |||
|
m10081
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
10102-15-5
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | |||
|
160916
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY | |||
|
SUB12315MIG
Created by
admin on Fri Dec 15 18:46:03 GMT 2023 , Edited by admin on Fri Dec 15 18:46:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |